North America

Fri
21
Jun

Cannabis and sports: Up against outdated rules

While cannabis legalization in Canada and some states in the U.S. may have opened doors to additional research into the plant’s health benefits, one area where the move towards acceptance continues to face hurdles is within professional sports leagues—at least for now.

A growing number of professional athletes are coming forward as cannabis advocates, calling for reduced penalties—or none at all—for using the plant, and highlighting its benefits for pain relief compared to options like opioids.

Fri
21
Jun

Predictive analysis in consumer data gives insight into cannabis’ future

Data is everything in cannabis right now. With this “data race” going strong, the cannabis industry is benefitting from useful data as firms compete to release the most interesting data on the profit-driving consumer behaviors of cannabis users.

Now, we have new insights on the why around cannabis use and overall cannabis attitudes, thanks to a new cannabis-related data set that the analysts call a “giant sandbox of data to play in.”

Fri
21
Jun

End of pre-employment drug testing doesn’t mean you can’t still be fired for marijuana

Although some jurisdictions across the United States are moving toward a policy that prevents pre-employment drug testing for marijuana, this amendment to that whiz-quiz way of life is not set up to ensure that everyone in the workforce that uses this substance is in the clear. Although there are many cases where drug testing for weed, or any other drug for that matter will not apply, the current marijuana ban under federal law demands that some workers pee clean, no matter what.

Fri
21
Jun

Global cannabis market will nearly triple to US$40.6B by 2024: Study

The value of the global cannabis market is set to soar to new heights, as more countries and American states legalize the drug, according to a new industry report.

Global legal spending on cannabis is forecast to be US$40.6 billion in 2024, nearly triple the US$14.9 billion estimated to be spent this year, according to Arcview Market Research and cannabis industry analysis firm BDS Analytics, which released its annual "State of the Legal Cannabis Markets" report on Thursday. 

"That's a conservative number as well if regulators wouldn't move as slowly as they are right now," said Tom Adams, managing director of industry intelligence at BDS Analytics, who co-authored the report in a phone interview with BNN Bloomberg. 

Fri
21
Jun

New study finds arthritis patients benefit from medical cannabis and CBD

Medical cannabis and CBD have proven over the years that they can help people suffering from arthritis. A new study claims that 90 percent of patients who tried cannabis felt relief from their symptoms.

Fri
21
Jun

Does cannabis have potential use for the treatment of HIV?

Even though cannabis and cannabinoid-derived pharmaceuticals are both frequently used by HIV/AIDS patients, several studies show that something interesting happens when cannabis is consumed.

What is HIV?

Human immunodeficiency virus (HIV) suppresses the immune system by killing specific white blood cells (CD4 T cells, otherwise known as T-Helper cells), who are in charge of destroying pathogens.

Infections are caused by either bacteria or viruses, and CD4 T cells react to those threats in two distinct ways:

Thu
20
Jun

Legal cannabis industry sets environmental and ethics goals

An alliance of large marijuana businesses had a message for the public Tuesday: We’re good corporate citizens.

The 45-member Global Cannabis Partnership, which includes Canopy Growth Corp. and other companies operating in the sector, issued guidelines aimed at minimizing greenhouse gas emissions and promoting ethical conduct and responsible pot use.

The emerging legal industry is “in a unique position to set a new bar for socially responsible practices,” the group’s executive director, Kim Wilson, said in a statement.

Thu
20
Jun

CannTrust to enter U.S. CBD market via hemp joint-venture in California

CannTrust Holdings Inc. (TRST.TO) plans to enter the U.S. market for CBD, starting with a hemp production joint-venture in California, it said on Wednesday.

The Vaughan, Ont.-based licensed producer has signed a non-binding letter of intent with Elk Grove Farming Company to secure hemp with high cannabidiol (CBD), the non-intoxicating compound found in cannabis and hemp.

Under the deal, the joint-venture will secure a long-term lease for more than 3,000 acres of farmland designated for hemp production in Southern California. It adds that it will process, formulate and sell hemp-derived CBD products.

This is the "first step" in CannTrust's development of "full-scale" U.S. operations, the company said.

Thu
20
Jun

Why CBD & THC are like fruits and veggies

A healthy diet means having the whole variety. It means having a wide range of foods for the complete range of vitamins and nutrients. 

But a healthy diet also means having cannabinoids like THC & CBD.

As humans, we naturally produce cannabinoids in our bodies. In fact, all animals produce cannabinoids and have an endocannabinoid system (ECS), which interacts with cannabinoids to regulate our pain, inflammation, immune systems, mood and thinking.

So just like vitamins, minerals, and other nutrients, cannabinoids may be just as essential to maintaining a healthy lifestyle.

Thu
20
Jun

A deal to form world’s largest marijuana company just took a big step forward

Canada’s leading marijuana producer Canopy Growth said Wednesday that shareholders approved its deal to acquire the American cannabis chain Acreage Holdings—contingent on the U.S. legalizing the growth, sale, and possession of the drug. While legal in the states where Acreage operates, marijuana is still illegal under U.S. federal law.

Pages

Subscribe to RSS - North America